Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Acquires 18,226 Shares

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw bought 18,226 shares of Retractable Technologies stock in a transaction dated Friday, January 10th. The shares were acquired at an average cost of $0.73 per share, with a total value of $13,304.98. Following the completion of the purchase, the chief executive officer now owns 14,966,204 shares in the company, valued at approximately $10,925,328.92. This trade represents a 0.12 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Retractable Technologies Trading Up 3.9 %

Shares of Retractable Technologies stock opened at $0.79 on Thursday. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. Retractable Technologies, Inc. has a twelve month low of $0.56 and a twelve month high of $1.34. The firm has a market capitalization of $23.54 million, a PE ratio of -1.46 and a beta of 1.94. The firm’s 50-day moving average price is $0.66 and its 200 day moving average price is $0.84.

Hedge Funds Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 7.58% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on shares of Retractable Technologies in a research report on Tuesday. They set a “hold” rating for the company.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.